Discover Medpace’s Q3 2025 earnings: record bookings, rising backlog, and robust revenue/EBITDA growth outlook for 2026.
Q3 2025 Management View Chairman, President & CEO Robert Holmes highlighted the completion of the four-year transformation plan announced in 2021, reporting the firm achieved a 1.3% return on average ...
Q3 2025 Management View CEO Vincenzo Vena opened the call highlighting "our third quarter results serve as a proof point that we are successfully executing on our strategy. We are focused on driving ...
John D. Lowe, President and CEO, indicated that "our strategies and investments are reaping benefits. Our customers are excited about our solutions. Our business continues to grow and win share and ...